Trial Profile
A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial to Evaluate Efficacy and Safety of Fentanyl TAIFUN Treatment after Titrated Dose Administration for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Aug 2023
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Acronyms FINDE
- Sponsors Akela Pharma
- 12 Aug 2023 This trial has been completed in Czech republic
- 18 Aug 2011 New trial record